{"DataElement":{"publicId":"4030378","version":"1","preferredName":"Cytotoxic Chemotherapy Maintenance Therapy Discontinued Prior Recurrent Disease Diagnosis Indicator","preferredDefinition":"information related to the discontinuation of the anticancer drugs that kill cells used as a continuation of treatment for an extended period of time to prevent relapse prior to the  recognition of the presence of the return of a disease after a period of remission.","longName":"Cyto_Main_Disc_Prio_Recu_Diag_","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"4030374","version":"1","preferredName":"Cytotoxic Chemotherapy Maintenance Therapy Discontinued Prior Recurrent Disease Diagnosis","preferredDefinition":"information related to the discontinuation of the anticancer drugs that kill cells used as a continuation of treatment for an extended period of time to prevent relapse prior to the  recognition of the presence of the return of a disease after a period of remission.","longName":"Cyto_Main_Disc_Prio_Recu_Diag","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"4030371","version":"1","preferredName":"Cytotoxic Chemotherapy Maintenance Therapy","preferredDefinition":"Anticancer drugs that kill cells, especially cancer cells.:Continuation of treatment for an extended period of time to prevent relapse.","longName":"C15681:C15688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytotoxic Chemotherapy","conceptCode":"C15681","definition":"A drug therapy that is used to destroy cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Maintenance Therapy","conceptCode":"C15688","definition":"Continuation of treatment for an extended period of time to prevent relapse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8AA58B-5557-C96C-E040-BB89AD436566","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"ONEDATA","dateModified":"2013-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4030372","version":"1","preferredName":"Discontinued Prior Recurrent Disease Diagnosis","preferredDefinition":"Discontinued; stopped permanently or temporarily.:Earlier in time or order.:The return of a disease after a period of remission.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C25484:C25629:C38155:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8AA58B-556A-C96C-E040-BB89AD436566","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"ONEDATA","dateModified":"2013-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8AA58B-557B-C96C-E040-BB89AD436566","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4030376","version":"1","preferredName":"Cytotoxic Chemotherapy Maintenance Therapy Discontinued Indicator","preferredDefinition":"information related to determining if the anticancer drugs that kill cells used as a continuation of treatment for an extended period of time to prevent relapse has stopped permanently or temporarily.","longName":"Cyto_Main_Disc_Indi","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not Applicable- No cytotoxic maintenance chemotherapy","valueDescription":"No Cytotoxic Maintenance Therapy Not Applicable","ValueMeaning":{"publicId":"4030377","version":"1","preferredName":"No Cytotoxic Maintenance Therapy Not Applicable","longName":"4030377","preferredDefinition":"The non-affirmative response to a question.: Having the ability to kill cells.: Continuation of treatment for an extended period of time to prevent relapse.: Determination that a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Cytotoxic","conceptCode":"C37893","definition":"Having the ability to kill cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Maintenance Therapy","conceptCode":"C15688","definition":"Continuation of treatment for an extended period of time to prevent relapse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8AA58B-55BA-C96C-E040-BB89AD436566","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8AA58B-55D3-C96C-E040-BB89AD436566","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"ONEDATA","dateModified":"2013-12-27","deletedIndicator":"No"},{"value":"No","valueDescription":"No ","ValueMeaning":{"publicId":"2567170","version":"1","preferredName":"No","longName":"2567170","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":"Updated to add NCIt concept relationship. Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8AA58B-55DD-C96C-E040-BB89AD436566","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"ONEDATA","dateModified":"2013-12-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3945562","version":"1","preferredName":"Yes","longName":"3945562","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA71051E-BFCC-9CF8-E040-BB89AD433955","latestVersionIndicator":"Yes","beginDate":"2013-11-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8AA58B-55E7-C96C-E040-BB89AD436566","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"ONEDATA","dateModified":"2013-12-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4030375","version":"1","preferredName":"Cytotoxic Chemotherapy Maintenance Therapy Discontinued Indicator","preferredDefinition":"Anticancer drugs that kill cells, especially cancer cells.:Continuation of treatment for an extended period of time to prevent relapse.:Discontinued; stopped permanently or temporarily.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C15681:C15688:C25484:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytotoxic Chemotherapy","conceptCode":"C15681","definition":"A drug therapy that is used to destroy cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Maintenance Therapy","conceptCode":"C15688","definition":"Continuation of treatment for an extended period of time to prevent relapse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8AA58B-5591-C96C-E040-BB89AD436566","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"ONEDATA","dateModified":"2013-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8AA58B-55A2-C96C-E040-BB89AD436566","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"REEVESD","dateModified":"2014-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"10000287","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"4104909","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"10000288","version":"1","longName":"GOG-0213","context":"NRG"}]}],"AlternateNames":[{"name":"Cyto_Main_Disc_Prio_Recu_Diag_","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"If the patient had cytotoxic","type":"Preferred Question Text","description":"If the patient had cytotoxic maintenance chemotherapy, was the therapy discontinued for a minimum of 6 months prior to documentation of recurrent disease?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8AA58B-55F2-C96C-E040-BB89AD436566","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"FORMBUILDER","dateModified":"2014-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}